Interestingly, the risk of metachronous CRC did not differ between carriers of MSH6/PMS2 variants who had partial colectomy and those of MLH1/MSH2 variants who had extensive colectomy (1.14, 0.55–2.36; p = 0.72) [57]. This evidence concerns the gene MSH2 and colorectal carcinoma.